News & Articles
Selected Filters:
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
Illumina announces the NovaSeq 6000 v1.5 reagent kit for whole genome sequencing
The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes
Thermo Fisher Scientific develops COVID-19 antibody assay targeting transplant community
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Role of serology in the next phase of COVID-19 investigation and response
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Important considerations for choosing a SARS-CoV-2 assay
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Avacta appoints COVID-19 rapid antigen test manufacturing partner
Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva
Are two antibodies better than one?
Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails
FDA approves GSK’s BLENREP for the treatment of patients with relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020
Siemens Healthineers obtains first FDA EUA for semi-quantitative antibody test
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
9 top resources for your COVID-19 & infectious disease research
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
Zymo Research releases free software to streamline COVID-19 test reporting
California Laboratories can now instantly transmit covid-19 data to the CalREDIE system
UK COVID-19 rapid antibody tests approved for professional use
Rapid antibody test receives CE mark for use by healthcare professionals
Akoya Biosciences collaborates with leading cancer center to discover predictive biomarkers for cancer
University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery
Horizon Discovery licenses CHOSOURCE platform to TrueBinding for development and commercialization of multiple biotherapeutics
TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform
FDA approves Roche’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapy
Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time
Roche provides an update on the phase III COVACTA trial in hospitalized COVID-19 patients
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
Validation of anti-COVID-19 drugs using the diagnostic tools of the future
Find out how LC-MS technology is being used to quantify the experimental drug remdesivir
Vela Diagnostics receives CE-IVD approval for automated COVID-19 detection test
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
























